- Home
- QURE vs HTH Comparison
QURE vs HTH Comparison
Compare QURE & HTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | QURE | HTH |
|---|---|---|
| Founded | 1998 | 1998 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 2007 | 2004 |
Fundamental Metrics
Financial Performance| Metric | QURE | HTH |
|---|---|---|
| Price | $24.81 | $34.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 12 | 2 |
| Target Price | ★ $58.55 | $34.00 |
| AVG Volume (30 Days) | ★ 3.0M | 379.9K |
| Earning Date | 11-10-2025 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.08% |
| EPS Growth | N/A | ★ 53.28 |
| EPS | N/A | ★ 2.50 |
| Revenue | $15,751,000.00 | ★ $1,259,399,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $153.45 | $1.64 |
| P/E Ratio | ★ N/A | $13.85 |
| Revenue Growth | N/A | ★ 7.66 |
| 52 Week Low | $7.76 | $26.67 |
| 52 Week High | $71.50 | $36.14 |
Technical Indicators
Market Signals| Indicator | QURE | HTH |
|---|---|---|
| Relative Strength Index (RSI) | 45.82 | 52.00 |
| Support Level | $19.29 | $34.27 |
| Resistance Level | $25.69 | $35.37 |
| Average True Range (ATR) | 1.56 | 0.61 |
| MACD | 1.19 | -0.09 |
| Stochastic Oscillator | 88.24 | 27.33 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About HTH Hilltop Holdings Inc.
Hilltop Holdings Inc is a Dallas-based financial holding company. The Company has two primary business units, PCC (banking and mortgage origination) and Securities Holdings (broker-dealer). The banking segment includes the operations of the Bank. The banking segment provides business and consumer banking services from offices located throughout Texas and generates revenue from its portfolio of earning assets. The broker-dealer segment includes the operations of Securities Holdings, which operates through its wholly owned subsidiaries Hilltop Securities, Asset Managment LLC, etc. The broker-dealer segment generates a majority of its revenues from fees and commissions earned from investment advisory and securities brokerage services. Majority of revenue is from Banking Segment.